scholarly journals Mechanisms of acquired resistance to androgen receptor targeting drugs in castration-resistant prostate cancer

2014 ◽  
Vol 14 (11) ◽  
pp. 1369-1378 ◽  
Author(s):  
David D Chism ◽  
Dinuka De Silva ◽  
Young E Whang
Keyword(s):  
Prostate Cancer ◽  
Androgen Receptor ◽  
Acquired Resistance ◽  
Castration Resistant Prostate Cancer ◽  
Receptor Targeting ◽  
Castration Resistant

Expression pattern of androgen receptors, AR-V7 and AR-567es, in circulating tumor cells and paired plasma-derived extracellular vesicles in metastatic castration resistant prostate cancer

The Analyst ◽  
2019 ◽  
Vol 144 (22) ◽  
pp. 6671-6680 ◽  
Author(s):  
Areti Strati ◽  
Martha Zavridou ◽  
Evangelos Bournakis ◽  
Sophia Mastoraki ◽  
Evi Lianidou
Keyword(s):  
Prostate Cancer ◽  
Androgen Receptor ◽  
Androgen Receptors ◽  
Acquired Resistance ◽  
Predictive Biomarker ◽  
Castration Resistant Prostate Cancer ◽  
Androgen Receptor Signaling ◽  
Castration Resistant ◽  
Signaling Inhibitors ◽  
Androgen Receptor Splice Variant

Androgen-receptor splice variant 7 (AR-V7) is a highly promising liquid biopsy predictive biomarker showing primary or acquired resistance to novel androgen receptor signaling inhibitors in metastatic castration resistant prostate cancer (mCRPC).

Outcomes of crossover between androgen receptor targeting drugs in the castration resistant prostate cancer registry (CAPRI)

2018 ◽  
Vol 17 (2) ◽  
pp. e878-e879
Author(s):  
M. Kuppen ◽  
H. Westgeest ◽  
F. Van Den Eertwegh ◽  
J. Van Moorselaar ◽  
R. De Wit ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Androgen Receptor ◽  
Cancer Registry ◽  
Castration Resistant Prostate Cancer ◽  
Receptor Targeting ◽  
Castration Resistant
Sign in / Sign up

Export Citation Format

Share Document